Charlotte's Web Holdings, Inc. (CWBHF)
OTCMKTS: CWBHF · Delayed Price · USD
+0.005 (3.09%)
May 24, 2024, 3:58 PM EDT - Market closed

Company Description

Charlotte's Web Holdings, Inc. is involved in the farming, manufacture, marketing, and sale of hemp-derived cannabidiol (CBD) wellness products.

The company's products categories include hemp extract oil tinctures, such as liquid products; gummies; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte's Web, ReCreate, CBD Medic, CBD Clinic, and Harmony Hemp brands.

Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds.

The company distributes its products through retail outlets and health care practitioners, as well as online through its website.

It has a collaboration between its CW Labs science division and Colorado State University's College of Agricultural Sciences; and scientific collaboration with McLean Hospital.

The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018.

The company was founded in 2013 and is headquartered in Louisville, Colorado.

Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings logo
Country Colombia
Founded 2018
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 164
CEO William J. Morachnick

Contact Details

700 Tech Court
Louisville, Colorado 80027
United States
Phone 1-720-617-7303

Stock Details

Ticker Symbol CWBHF
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001750155
CUSIP Number 16106R109
ISIN Number CA16106R1091
Employer ID 98-1508633
SIC Code 0100

Key Executives

Name Position
Jared Stanley Co-Founder and Chief Commercial Officer
Greg Gould Chief Administration Officer
Stephen David Rogers Senior Vice President, General Counsel and ?Corporate Secretary.
William J. Morachnick Chief Executive Officer and Non-Independent Director
Jessica Saxton Chief Financial Officer
Sarah Cambridge Corporate Controller and Chief Accounting Officer
Dr. Marcel Bonn-Miller Ph.D. Chief Scientific Officer
Cory Pala Director of Investor Relations
Kelly Shea Senior Vice President of Government Affairs and Corporate Communications
Andrew Shafer Chief Marketing Officer

Latest SEC Filings

Date Type Title
May 8, 2024 10-Q Quarterly Report
May 8, 2024 8-K Current Report
Apr 29, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 29, 2024 8-K Current Report
Apr 29, 2024 ARS Filing
Apr 29, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 29, 2024 DEF 14A Other definitive proxy statements
Mar 21, 2024 S-8 Securities to be offered to employees in employee benefit plans
Mar 21, 2024 10-K Annual Report
Mar 21, 2024 8-K Current Report